Multiple Myeloma Clinical Trial
Descartes-25 in Relapsed/Refractory Multiple Myeloma
This is a Phase I/IIa dose-escalation study to evaluate the safety, tolerability, and preliminary efficacy of an allogeneic Mesenchymal Stem Cell (Descartes-25) product secreting a bispecific protein and other proteins in patients with Relapsed/Refractory Multiple Myeloma.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Shreveport Louisiana, 71103, United States More Info
Bethesda Maryland, 20817, United States More Info
Madison Wisconsin, 53226, United States More Info
Ankara Anatolia, 06200, Turkey More Info
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.